Screening for high fracture risk.

McCloskey, E; Harvey, N; Johansson, H; Lorentzon, M; Vandenput, L; Kanis, J A

McCloskey, E; Harvey, N; Johansson, H; Lorentzon, M; Vandenput, L; Kanis, J A.

Afiliação

McCloskey E; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. e.v.mccloskey@sheffield.ac.uk.
Harvey N; Centre for Integrated research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK. e.v.mccloskey@sheffield.ac.uk.
Johansson H; Metabolic Bone Centre, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK. e.v.mccloskey@sheffield.ac.uk.
Lorentzon M; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
Vandenput L; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, UK.
Kanis JA; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.

Osteoporos Int ; 31(6): 1179-1180, 2020 06.

Article em En | MEDLINE | ID: mdl-32333067

Assuntos

Fraturas por Osteoporose; Humanos; Fraturas por Osteoporose/epidemiologia; Fraturas por Osteoporose/etiologia; Fraturas por Osteoporose/prevenção & controle

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fraturas por Osteoporose Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Osteoporos Int Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google